Albumin concentration significantly impacts on free teicoplanin plasma concentrations in non-critically ill patients with chronic bone sepsis.
暂无分享,去创建一个
J. Lipman | A. Brink | J. Roberts | V. Schillack | L. van Niekerk | G. Richards | N. Rapeport | E E G Lautenbach | E. E. G. Lautenbach
[1] J. Rello,et al. Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: lessons from the DALI Study. , 2014, International journal of antimicrobial agents.
[2] M. Roberts,et al. Altered Pharmacokinetics of Piperacillin in Febrile Neutropenic Patients with Hematological Malignancy , 2014, Antimicrobial Agents and Chemotherapy.
[3] M. Doi,et al. Plasma exposure of free linezolid and its ratio to minimum inhibitory concentration varies in critically ill patients. , 2013, International journal of antimicrobial agents.
[4] J. Roberts,et al. Protein Binding of β-Lactam Antibiotics in Critically Ill Patients: Can We Successfully Predict Unbound Concentrations? , 2013, Antimicrobial Agents and Chemotherapy.
[5] J. Rello,et al. The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill Patients , 2011, Clinical pharmacokinetics.
[6] J. Rello,et al. Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokinetics. , 2010, The Journal of antimicrobial chemotherapy.
[7] R. Seaton,et al. Development of teicoplanin dosage guidelines for patients treated within an outpatient parenteral antibiotic therapy (OPAT) programme. , 2009, The Journal of antimicrobial chemotherapy.
[8] A. Brink,et al. Pharmacokinetics of once-daily dosing of ertapenem in critically ill patients with severe sepsis. , 2009, International journal of antimicrobial agents.
[9] A. Brink,et al. Recommendations to achieve rapid therapeutic teicoplanin plasma concentrations in adult hospitalised patients treated for sepsis. , 2008, International journal of antimicrobial agents.
[10] B. Bourgeois,et al. Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies , 2008, Epilepsia.
[11] N. Goto,et al. Variability in Teicoplanin Protein Binding and Its Prediction Using Serum Albumin Concentrations , 2007, Therapeutic drug monitoring.
[12] D. Soy,et al. Teicoplanin Population Pharmacokinetic Analysis in Hospitalized Patients , 2006, Therapeutic drug monitoring.
[13] P. Viale,et al. The effect of multifactorial, multidisciplinary educational interventions on appropriate use of teicoplanin. , 2006, International journal of antimicrobial agents.
[14] B. Debaene,et al. Steady-state trough serum and epithelial lining fluid concentrations of teicoplanin 12 mg/kg per day in patients with ventilator-associated pneumonia , 2006, Intensive Care Medicine.
[15] R. Greenberg. Treatment of bone, joint, and vascular-access-associated gram-positive bacterial infections with teicoplanin , 1990, Antimicrobial Agents and Chemotherapy.